Close
ACHEMA MIDDLE EAST 2026
DDF Summit 2025

Tag: America

Browse our exclusive articles!

Exelixis’ Phase III prostate cancer trial of cabozantinib fails to meet primary endpoint

US-based biopharmaceutical firm Exelixis has reported disappointing top-line results from the final analysis of COMET-1, the Phase III trial of cabozantinib in men with...

InnoPharma Announces FDA Approval of Decitabine for Injection, a Generic Version of DACOGEN®

InnoPharma, Inc. today announced the approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for decitabine for...

FDA lifts partial clinical hold on OncoMed’s vantictumab cancer drug trials

The US Food and Drug Administration (FDA) has lifted a partial hold on patient enrolments for three Phase Ib clinical trials evaluating OncoMed Pharmaceuticals'...

Novo Nordisk introduces Ryzodeg in Mexico for type 2 diabetes

Denmark-based Novo Nordisk has introduced Ryzodeg (insulin degludec/insulin aspart) in Mexico, which will be used to treat adult patients suffering from type 2 diabetes....

Senesco completes patient enrolment in Phase Ib/IIa SNS01-T trial

US-based biotech firm Senesco Technologies has completed patient enrolment in its ongoing Phase Ib/IIa clinical trial of SNS01-T to treat patients with relapsed or...

Popular

Building the Right Team and Resource Model to Support Quality System and Validation Activities

Since life science quality and validation projects can vary...

Merck and Blackstone Enter R&D Funding Agreement for sac-TMT

Merck, recognized as MSD outside the U.S. and Canada,...

FDA Approves J&J’s DARZALEX FASPRO for HR-SMM in Adults

Johnson & Johnson said the U.S. Food and Drug...

FDA Approves UCB’s KYGEVVI for Thymidine Kinase 2 Deficiency

UCB, a leading global biopharmaceutical company, has announced that...

Subscribe

spot_imgspot_img